← USPTO Patent Grants

Wearable drug delivery device

Grant US12582766B1 Kind: B1 Mar 24, 2026

Assignee

Fresenius Kabi Deutschland, GmbH

Inventors

David R. Schiff, Sharon D. West

Abstract

A drug delivery device has a housing with an adhesive pad associated with a lower surface of the housing and configured to removably attach to a human body surface. A drug container is positioned within the housing, with a plunger movably positioned within the drug container and with a needle fluidically connected to the drug container and configured to define at least a portion of a fluid flow path between the drug container and the human body surface. The drug delivery device also includes a buzzer and an indicator light for providing indications. A controller is configured to control the components of the drug delivery device to execute a drug delivery routine. A method of delivering pegfilgrastim from a drug delivery device includes providing an audible indication that the drug delivery device is activated, executing a drug delivery routine, and providing first and second indications during drug delivery.

CPC Classifications

A61M 5/148 A61M 5/1483 A61M 5/152 A61M 5/1555 A61M 5/16881 A61M 5/14248 A61M 5/1452 A61M 2005/14252 A61M 2202/0007

Filing Date

2025-06-13

Application No.

19237456

Claims

27